DAPACONAZOLE
UNII H2976538CX

Substance Identification & Data

This profile provides standardized clinical and technical data for Dapaconazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H2976538CX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1269726-67-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H2976538CX

CAS Registry Number

1269726-67-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAPACONAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H15Cl2F3N2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FUAHXHWSMYFWGE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C169876

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

51001696

Unique identification number in the NCBI database of chemical substances.

INN ID

9902

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(c1ccc(Cl)cc1Cl)(OCc2ccc(C(F)(F)F)cc2)Cn3cncc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dapaconazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.